Display Settings:

Format

Send to:

Choose Destination
    Bioorg Med Chem. 2010 Aug 15;18(16):6089-98. Epub 2010 Jun 25.

    A new metabotropic glutamate receptor agonist with in vivo anti-allodynic activity.

    Source

    Discipline of Chemistry, The University of Adelaide, Adelaide, Australia.

    Abstract

    As part of the vital search towards improved therapeutic agents for the treatment of neuropathic pain, the central nervous system glutamate receptors have become a major focus of research. Outlined herein are the syntheses of two new biologically active 3'-cycloalkyl-substituted carboxycyclopropylglycines, utilizing novel synthetic chemistry. The reaction between substituted 1,2-dioxines and an aminophosphonate furnished the cyclopropane core in a single step with all required stereochemistry of pendant groups. In vitro binding assays at metabotropic glutamate receptors revealed selective activity. In vivo testing in a rodent model of neuropathic pain indicated one amino acid significantly and dose-dependently decreased mechanical allodynia.

    Copyright 2010 Elsevier Ltd. All rights reserved.

    PMID:
    20638290
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk